Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

4.2%

1 terminated/withdrawn out of 24 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

4%

1 trials in Phase 3/4

Results Transparency

25%

3 of 12 completed trials have results

Key Signals

6 recruiting3 with results

Enrollment Performance

Analytics

Phase 1
11(47.8%)
Phase 2
9(39.1%)
Early Phase 1
2(8.7%)
Phase 3
1(4.3%)
23Total
Phase 1(11)
Phase 2(9)
Early Phase 1(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (24)

Showing 20 of 24 trials
NCT07251491Phase 1Recruiting

Psilocybin to Treat Depression in Spinal Cord Injury

Role: collaborator

NCT04353921Terminated

PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder

Role: lead

NCT06308653Phase 3Active Not Recruiting

Psilocybin for Major Depressive Disorder (MDD)

Role: lead

NCT03866174Phase 2Completed

A Study of Psilocybin for Major Depressive Disorder (MDD)

Role: lead

NCT06430541Phase 1Recruiting

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Role: collaborator

NCT07227909Phase 2Not Yet Recruiting

NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy

Role: collaborator

NCT05546658Early Phase 1Active Not Recruiting

Effects of Psilocybin in Obsessive Compulsive Disorder

Role: collaborator

NCT04620759Phase 2Active Not Recruiting

Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

Role: collaborator

NCT06442423Phase 1Recruiting

Open-Label Psilocybin Study in Transdiagnostic Population

Role: collaborator

NCT04950608Phase 2Completed

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care

Role: collaborator

NCT07053917Phase 1Recruiting

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

Role: collaborator

NCT06888128Phase 2Recruiting

State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma

Role: collaborator

NCT05399498Phase 2Completed

Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Role: collaborator

NCT06407635Phase 1Active Not Recruiting

A Study of Psilocybin for PTSD

Role: collaborator

NCT05305105Phase 1Completed

Effects of Psilocybin in Post-Treatment Lyme Disease

Role: collaborator

NCT06512194Phase 2Recruiting

Investigation to Understand and Optimize Psilocybin

Role: collaborator

NCT05592379Phase 1Completed

Consciousness, Psilocybin, and Well-Being

Role: collaborator

NCT04670081Phase 2Completed

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression

Role: collaborator

NCT05557643Phase 1Completed

PAPR: PAP + MBSR for Front-line Healthcare Provider COVID-19 Related Burnout

Role: collaborator

NCT04522804Early Phase 1Completed

Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer

Role: collaborator